Immunosuppressive treatment in collagen diseases
Machtey, I.
Harefuah 84(2): 101-102
1973
ISSN/ISBN: 0017-7768 PMID: 4704609 Document Number: 66231
Document emailed within 1 workday
Related Documents
Marmont, A.; Rossi, F.; Bordo, D. 1973: Current aspects of immunosuppressive therapy of collagen diseases Minerva Medica 64(46): 2436-2450Holm, G. 1976: Immunosuppressive treatment of chronic diseases Lakartidningen 73(17): 1623
Ishioka, S.; Maeda, A.; Hiyama, K.; Yamakido, M. 1995: Pulmonary manifestation of collagen vascular diseases: role of cytokines in interstitial pneumonia associated with collagen vascular diseases Nihon Kyobu Shikkan Gakkai Zasshi 33 Suppl: 277-283
Wasik, F.; Miklaszewska, M.; Nockowska, M. 1975: Treatment of some skin diseases with immunosuppressive drugs Przeglad Dermatologiczny 62(1): 103-108
Ten Berge, R.J.M. 2002: Treatment of autoimmune diseases and vasculitides with immunosuppressive drugs Netherlands Journal of Medicine 60(7): 298-299
Calin, A. 1980: The treatment of collagen diseases Der Internist 21(11): 697-701
Razzaque, M.S.; Nazneen, A.; Taguchi, T. 1998: Immunolocalization of collagen and collagen-binding heat shock protein 47 in fibrotic lung diseases Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 11(12): 1183-1188
Heidelmann, G.; Fleischer, J.; Schwenke, R. 1971: Case report on the treatment with azathioprine of collagen diseases Das Deutsche Gesundheitswesen 26(1): 17-24
Yamagata, S.; Watanabe, H. 1976: Problem of overlapping of collagen diseases with other related diseases or autoimmune diseases--ulcerative colitis and Crohn's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 34(6): 1167-1172
Yamanaka, M. 1976: Problem of overlapping of collagen diseases with other related diseases or autoimmune diseases--thrombotic thrombopenic purpura-- Nihon Rinsho. Japanese Journal of Clinical Medicine 34(6): 1147-1153
Slavin, S. 1993: Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT Bone Marrow Transplantation 12(1): 85-88
Gandzha, I.M.; Furkalo, N.K. 1974: Indicators of lipid metabolism and blood coagulation in patients with collagen diseases in the process of treatment with immunodepressants Vrachebnoe Delo 9: 6-8
Carbon, C.; Saimot, G. 1972: Parasitic diseases and collagen diseases. Hypothesis and prospective models La Nouvelle Presse Medicale 1(24): 1619-1622
Vildé, J.L. 1976: Pathophysiology of infectious diseases in immunosuppressive therapy Pathologie-Biologie 24(2): 133-139
Cemalović-Boko, Z.; Cemalović-Pernar, A.; Richter, B. 1985: Immunosuppressive therapy in neurologic diseases and antibodies against Toxoplasma gondii Neurologija 34(1-4): 109-120
Rolović, Z.; Rolović, M. 1971: Bases for the use of immunosuppressive therapy in systemic connective tissue diseases Srpski Arhiv Za Celokupno Lekarstvo 98(9): 1177-1185
Floersheim, G.L. 1970: Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases Schweizerische Medizinische Wochenschrift 100(52): 2241-2247
Andreev, I.; Chukanov, K.; Tishkov, I.; Stefanova, G.; Khausvald, I. 1974: Therapeutic results of immunologic kidney diseases treated with immunosuppressive drugs Vutreshni Bolesti 13(3): 77-86
Rothschild, B. 1984: Collagen-vascular diseases Primary Care 11(2): 307-323
Kaplan, J.; Maroteaux, P.; Frezal, J. 1986: The genetics of collagen diseases Annales de Biologie Clinique 44(3): 289-295